Burning Rock Biotech Limited (BNR)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 09:41AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 78.99M |
| Enterprise Value | -5.70M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.04 |
| Price/Book (mrq) | 0.73 |
| Enterprise Value/Revenue | -0.01 |
| Enterprise Value/EBITDA | 0.01 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.18 |
| 52-Week Change 3 | -73.17% |
| S&P500 52-Week Change 3 | 25.59% |
| 52 Week High 3 | 2.9500 |
| 52 Week Low 3 | 0.5720 |
| 50-Day Moving Average 3 | 0.7657 |
| 200-Day Moving Average 3 | 0.9841 |
Share Statistics
| Avg Vol (3 month) 3 | 53.39k |
| Avg Vol (10 day) 3 | 69.33k |
| Shares Outstanding 5 | 102.59M |
| Implied Shares Outstanding 6 | 102.59M |
| Float 8 | 55.31M |
| % Held by Insiders 1 | 0.12% |
| % Held by Institutions 1 | 60.93% |
| Shares Short (Apr 15, 2024) 4 | 397.91k |
| Short Ratio (Apr 15, 2024) 4 | 14.61 |
| Short % of Float (Apr 15, 2024) 4 | 0.04% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 0.04% |
| Shares Short (prior month Mar 15, 2024) 4 | 410.3k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in CNY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -121.63% |
| Operating Margin (ttm) | -137.36% |
Management Effectiveness
| Return on Assets (ttm) | -31.84% |
| Return on Equity (ttm) | -67.85% |
Income Statement
| Revenue (ttm) | 537.44M |
| Revenue Per Share (ttm) | 5.25 |
| Quarterly Revenue Growth (yoy) | -14.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -537.87M |
| Net Income Avi to Common (ttm) | -653.69M |
| Diluted EPS (ttm) | -0.9000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 628.5M |
| Total Cash Per Share (mrq) | 6.13 |
| Total Debt (mrq) | 12.32M |
| Total Debt/Equity (mrq) | 1.60% |
| Current Ratio (mrq) | 3.36 |
| Book Value Per Share (mrq) | 7.50 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -255.78M |
| Levered Free Cash Flow (ttm) | -57.45M |
© 2024 Yahoo. All rights reserved.